PDCD1 and liver cancer: To improve the immune response rate of patients with liver cancer and increase the efficacy of anti-PD-1, it is urgent to further study the immune microenvironment of liver cancer and find more effective tumor therapeutic targets, so as to achieve the purpose of precise treatment.